Khatore Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 1.51 M
- Company Age 37 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.60 M
About Khatore Pharmaceuticals
Khatore Pharmaceuticals Pvt Ltd (KPPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 May 1987 and has a history of 37 years and nine months. Its registered office is in Kendujhar, Odisha, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.51 M.
The company currently has active open charges totaling ₹2.60 M.
Vijay Khatore and Reeta Khatore serve as directors at the Company.
Company Details
-
Location
Kendujhar, Odisha, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24231OR1987PTC001836
-
Company No.
001836
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
14 May 1987
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Cuttack
Industry
What products or services does Khatore Pharmaceuticals Pvt Ltd offer?
Khatore Pharmaceuticals Pvt Ltd offers a wide range of products and services, including Liver Supplement, Ayurvedic Liver Tablets Capsules, Ayurvedic Medicine, Ayurvedic Menstrual Cycle Medicine.
Who are the key members and board of directors at Khatore Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijay Khatore
|
Director | 14-May-1987 | Current |
|
Reeta Khatore
|
Director | 01-Apr-2011 | Current |
Financial Performance of Khatore Pharmaceuticals.
Khatore Pharmaceuticals Pvt Ltd, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Khatore Pharmaceuticals?
In 2017, Khatore Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹2.60 M
₹0
Charges Breakdown by Lending Institutions
- Idbi Bank Limited : 0.13 Cr
- State Bank Of India : 0.13 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Jan 2018 | Idbi Bank Limited | ₹1.30 M | Open |
| 12 Dec 2003 | State Bank Of India | ₹1.30 M | Open |
How Many Employees Work at Khatore Pharmaceuticals?
Unlock and access historical data on people associated with Khatore Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Khatore Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Khatore Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
